Alternative splicing is a key feature of cancer [36-38] including CRC [35,39] and the identification of RBFOX1 targets in CRC will help to determine if RBFOX1 deletion is a critical feature of dysfunctional splicing in CRC. The gene discussed is RBFOX1; the disease is cancer.